Laszlo Nagy

Prof. Laszlo Nagy


Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 1997 in Cell
Verified
Journal Article
Closed access
HCHongwu Chen
Hongwu Chen
RLRichard J Lin
Richard J Lin
RSR.Louis Schiltz
R.Louis Schiltz
DCDebabrata Chakravarti
Debabrata Chakravarti
ANAlyssa Nash
Alyssa Nash
RERonald M Evans
Ronald M Evans

1 May 1997 in Cell
Verified
Journal Article
Closed access
LNLaszlo Nagy
Laszlo Nagy
HKHung-Ying Kao
Hung-Ying Kao
DCDebabrata Chakravarti
Debabrata Chakravarti
RLRichard J Lin
Richard J Lin
CHChristian A Hassig
Christian A Hassig
RERonald M Evans
Ronald M Evans

19 February 1998 in Nature
Verified
Journal Article
Closed access
PDF file
RLRichard J. Lin
Richard J. Lin
LNLaszlo Nagy
Laszlo Nagy
SISatoshi Inoue
Satoshi Inoue
WSWenlin Shao
Wenlin Shao
WMWilson H. Miller
Wilson H. Miller
RERonald M. Evans
Ronald M. Evans

1 August 2011 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
TVTamas Varga
Tamas Varga
ZCZsolt Czimmerer
Zsolt Czimmerer
LNLaszlo Nagy
Laszlo Nagy

17 August 2008 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
TIToshimasa Itoh
Toshimasa Itoh
LFLouise Fairall
Louise Fairall
KAKush Amin
Kush Amin
YIYuka Inaba
Yuka Inaba
ASAttila Szanto
Attila Szanto
JSJohn W R Schwabe
John W R Schwabe

1 November 2010 in Immunity
Verified
Journal Article
Open access
ASAttila Szanto
Attila Szanto
Balint BalintBalint Balint
Balint Balint
ZNZsuzsanna S. Nagy
Zsuzsanna S. Nagy
Endre BartaEndre Barta
Endre Barta
BDBalázs Dezso
Balázs Dezso
LNLaszlo Nagy
Laszlo Nagy
Peroxisome proliferator-activated receptor γ (PPARγ) is a lipid-activated transcription factor regulating lipid metabolism and inflammatory response in macrophages and dendritic cells (DCs). These immune cells exposed to distinct inflammatory milieu show cell type specification as a result of altered gene expression. We demonstrate here a mechanism how inflammatory molecules modulate PPARγ signaling in distinct subsets of cells. Proinflammatory molecules inhibited whereas interleukin-4 (IL-4) stimulated PPARγ activity in macrophages and DCs. Furthermore, IL-4 signaling augmented PPARγ activity through an interaction between PPARγ and signal transducer and activators of transcription 6 (STAT6) on promoters of PPARγ target genes, including FABP4. Thus, STAT6 acts as a facilitating factor for PPARγ by promoting DNA binding and consequently increasing the number of regulated genes and the magnitude of responses. This interaction, underpinning cell type-specific responses, represents a unique way of controlling nuclear receptor signaling by inflammatory molecules in immune cells.